Global > United Kingdom > Industries > Life Sciences

Life Sciences

Clear advice in an uncertain world

The global life sciences industry continues to face periods of uncertainty, with mounting pressures experienced across the sector.

We look at issues such as increased regulation, dialogue on personalised healthcare programmes, the ubiquitous need to innovate and pricing pressures on an already challenged industry by those that end up paying the bill.

In addition, the UK industry is having to tackle mounting challenges and competition from around the world as countries like India emerge. Our industry specialists from across Deloitte provide an extensive depth of knowledge on the range of current issues experienced by the pharmaceuticals, biotechnology, medical device and private healthcare industries.

MORE Research and insight

2011 Survey of Health Care Consumers in UK
This is the second consecutive year Deloitte has published research on consumers' behaviors, attitudes and unmet needs based on their personal experiences and observations of the UK health care systems. View all country reports
Measuring the return from innovation
Last year Deloitte and Thomson Reuters conducted an analysis into value measurement at the "whole R&D business" level using Internal Rate of Return (IRR). This year, we have extended our analysis, looking at the same cohort of companies one year on.
Winning in Life Sciences Are you agile enough?
Winning in Life Science brochure “Are you agile enough?” is the second iteration of a series which highlights Deloitte’s key propositions to the Life Science and Healthcare industries many and varied challenges.
The future of the life sciences industries: Aftermath of the global recession
The global recession has undoubtedly affected the life sciences industries - the question is whether the impact is temporary or more strategic and lasting?
Perspective on health care behaviours, attitudes and unmet needs of six countries
With the state of Healthcare in the UK creating hot debate in the lead up to the May 6th general election, Deloitte has conducted its inaugural study in to Healthcare attitudes and behaviours in the UK. Along with this, five other national studies and an overarching global report have been brought together to form a unique patient perspective.

Useful links

Highlights

FT Global Pharmaceutical and Biotechnology conference 2011
Sign up to the conference

Find out more

Deloitte UK Centre for Health Solutions

Share this page

Follow:

© 2012 Deloitte LLP. All rights reserved. Deloitte refers to one or more of Deloitte Touche Tohmatsu Limited, a UK private company limited by guarantee, and its network of member firms, each of which is a legally separate and independent entity.

Please see About Deloitte for a detailed description of the legal structure of Deloitte Touche Tohmatsu Limited and its Member Firms. View our accessibility statement.

Get in touch